Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 60760-766

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 60760-766). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

766-30 (Cyclobenzaprine 766 30)

766-30 (Cyclobenzaprine 766 30)
Label for Cyclobenzaprine Hydrochloride Tablets USP 5 mg, film-coated oral tablets. The quantity is 30 tablets. The label shows the NDC 60760-766-30 and states it is packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ, and manufactured by Rubicon Research Private Limited in India. The label includes storage instructions and identifies the product as prescription only.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride, showing a tricyclic ring system attached to a side chain with an amine group and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.